ArticleDiabetes technology & therapeutics2022
"Fear That One Day I May Not Be Able to Afford Insulin": The Emotional Burden of Diabetes Costs During Emerging Adulthood.
Article in Diabetes technology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 22 citations in OpenAlex.
- Life stage transitions for people with type 1 diabetes.The lancet. Diabetes & endocrinology · 2025Review
- Insights on Improving Health Insurance Literacy in Diabetes.The Journal of clinical endocrinology and metabolism · 2025Review
- Insulin Insecurity and Its Subsequent Impact on Emerging Adults and Families of Children With Type 1 Diabetes.Diabetes spectrum : a publication of the American Diabetes Association · 2025Article
- "Can I afford to live today?" The emotional toll of navigating the healthcare system with type 1 diabetes.Frontiers in endocrinology · 2025Article
- The Type of Patient Training Does Not Impact Outcomes in the First 90 Days of Automated Insulin Delivery Use.Diabetes technology & therapeutics · 2024Article
- Empowering emerging adults with type 1 diabetes: crafting a financial and health insurance toolkit through community-based participatory action research.Research involvement and engagement · 2024Article
- Financial stress in emerging adults with type 1 diabetes: a mini review integrating lessons from cancer research.Frontiers in clinical diabetes and healthcare · 2024Review
- Transition to self-management among emerging adults with type 1 diabetes: a mixed methods study.Frontiers in clinical diabetes and healthcare · 2024Article
- Mobilizing Research to Understand the Impact of Financial Toxicity Among Adolescents and Young Adults Diagnosed With Chronic Diseases.The Journal of adolescent health : official publication of the Society for Adolescent Medicine · 2023Article
- Advances in the management of type 2 diabetes in adults.BMJ medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
Emerging adults (EAs) with type 1 diabetes (T1D) often experience challenges in diabetes management, in particular transitioning to financial independence. EAs 18-30 years of age with T1D completed online surveys about diabetes distress and an open-ended query about the most important worry among survey questions. Most of the 287 respondents (89.5%) endorsed "Agree" or "Somewhat agree" to the statement "I worry about the cost of diabetes." Responses did not differ by gender, age, diabetes duration, race/ethnicity, diabetes technology use, student status, income, or insurance status. However, a greater proportion of those not endorsing cost as a substantial burden achieved A1c <7% (92.9%) versus those who were neutral (46.2%) or who endorsed cost as a burden (50.6%) (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.